Crossmark

Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas—prognostic significance in different biological sub-groups

Crossref DOI link: https://doi.org/10.1007/s11060-025-05215-6

Published Online: 2025-09-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tini, Paolo

Donnini, Flavio

Marampon, Francesco

Pastina, Pierpaolo

Rubino, Giovanni

Battaglia, Giuseppe

Chibbaro, Salvatore

Cerase, Alfonso

Mazzei, Maria Antonietta

Desideri, Isacco

Minniti, Giuseppe
Funding

Funding for this research was provided by:

Università degli Studi di Siena
License Information

Text and Data Mining valid from 2025-09-25

Version of Record valid from 2025-09-25
More Information

Article History

Received: 18 July 2025

Accepted: 14 August 2025

First Online: 25 September 2025

Declarations

:

: The authors declare no competing interests.

: The study was approved by the local Ethics Committee (protocol GLIOMARKERSOBS_2025-1, approved May 6, 2025). All patients provided informed consent for treatment and inclusion of their anonymized data in research analyses.

Document is current

Any future updates will be listed below